Risk Recall of Complications Associated with Vestibular Schwannoma Treatment
Overview
Otorhinolaryngology
Authors
Affiliations
Objective: To assess the risk recall of complications among patients who underwent different vestibular schwannoma (VS) treatments.
Study Design: Patients with VS completed a voluntary and anonymous survey.
Setting: Survey links were distributed via the Acoustic Neuroma Association (ANA) website, Facebook, and email list.
Subjects And Methods: Surveys were distributed to ANA members from January to March 2017. Of the 3200 ANA members with a VS diagnosis at the time of survey distribution, 789 (25%) completed the survey.
Results: Subjects reported the following incidence of posttreatment complications: imbalance (60%), hearing issues (51%), dry eyes (30%), headache (29%), and facial weakness (27%). Overall, 188 (25%) recalled remembering all the risks associated with their treatment. Among those in the surgical cohort (52%) who experienced balance issues, facial weakness, cerebrospinal fluid leak, meningitis, and stroke, 73%, 91%, 77%, 67%, and 33% claimed recall of these associated risks. Among those in the radiosurgery cohort (28%) who experienced balance issues, facial weakness, and hydrocephalus, 56%, 52%, and 60% recalled discussions of those risks. Patients with higher-level education ( = .026) and those who underwent surgery ( = .001) had a significantly higher risk recall ratio, while sex, age, and tumor size were not significant contributing factors.
Conclusion: Not all patients with VS who experienced treatment complications recalled remembering those risks being discussed with them. Patients with higher education and those who underwent surgery had a better recall of risks associated with different treatment modalities. The risk recall ratio of patients experiencing complications ranged 33% to 91%, suggesting an opportunity for decision-making and discussion improvement.
Post-Operative Outcome Predictions in Vestibular Schwannoma Using Machine Learning Algorithms.
Dichter A, Bhatt K, Liu M, Park T, Djalilian H, Abouzari M J Pers Med. 2024; 14(12).
PMID: 39728082 PMC: 11678011. DOI: 10.3390/jpm14121170.
Shi X, Liu Y, Zhang Z, Tao B, Zhang D, Jiang Q CNS Neurosci Ther. 2023; 30(4):e14526.
PMID: 37990346 PMC: 11017437. DOI: 10.1111/cns.14526.
Goshtasbi K, Abouzari M, Djalilian H Otol Neurotol. 2019; 40(7):979-980.
PMID: 31295209 PMC: 8048122. DOI: 10.1097/MAO.0000000000002307.